STING1 and melanoma: Pharmacologic inhibition of DNA methylation could reinstate functional STING signaling, which is effective to restore STING signaling to improve the antigenicity of tumor cells through the upregulation of MHC class I molecules, facilitating the recognition and killing of melanoma cells by cytotoxic T cells within TME (18).